Examining HIV Treatment Adherence During Early Disease

CompletedOBSERVATIONAL
Enrollment

904

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Medication AdherenceHIV
Trial Locations (2)

7760

Hannan Crusaid Treatment Centre (HCTC), Gugulethu, Cape Town

Unknown

Immune Suppression Syndrome (ISS) Clinic, Mbarara

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Mbarara University of Science and Technology

OTHER

collaborator

Desmond Tutu HIV Centre

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02419066 - Examining HIV Treatment Adherence During Early Disease | Biotech Hunter | Biotech Hunter